Paul Solman of PBS Newshour speaks to Prof. Andrew Lo about getting investors to finance research into treatments for cancer and genetic diseases. “We now have the opportunity to treat disease in many, many different ways. We just don’t have enough money to explore all of the different pathways,” explains Prof. Lo.
STAT reporter Dominic Smith highlights how MIT researchers are applying the art of origami to developing a new way to deliver cancer medications. Prof. Michael Cima explains that, “the idea here was, is there a way we could do a minimally invasive procedure to deploy some sort of device that will deliver the drug over that entire course of the therapy?”
Prof. Regina Barzilay, a breast cancer survivor, participated in a Washington Post Live discussion about “her own experience with the disease and how she uses data and machine learning to advance detection and treatment.”
Boston Magazine reporter Jamie Ducharme writes that MIT researchers have developed a non-invasive technique for assessing cells, which could eventually be used to help diagnose diseases. The researchers are “working with doctors at Massachusetts General Hospital, who hope to use the technique to study diseases such as cancer and asthma.”
Scientific American reporter Lindsay Brownell writes that MIT researchers have developed a technique to enlarge pathology samples. “Not only are expanded samples easier to see because they are larger and more transparent, fluorescent tags and other labels can also be added to track individual molecules of interest.”
Reporting for WBUR on efforts to develop a treatment for glioblastoma, Karen Weintraub highlights Prof. Paula Hammond’s work creating a method to get drugs across the body’s blood-brain barrier. “By disguising her tiny, drug-carrying nanoparticles as proteins that normally carry iron across the barrier, she's been able to sneak them past the armor that lines the brain’s blood vessels.”
Reporting for WBUR, Karen Weintraub speaks with Profs. Angela Belcher, Sangeeta Bhatia and Paula Hammond about their work developing tiny tools to target cancer cells. Bhatia explains that their collaboration feels like, “a dream team of people that are interested in nanoscience and nanotechnology and focusing those advances on cancer.”
Prof. Regina Barzilay’s research group is working with MGH to use artificial intelligence and machine learning to improve cancer diagnoses, reports CNBC’s Meg Tirrell. The group also hopes to allow doctors to use “the huge quantities of data available on patients to make more personalized treatment decisions,” explains Tirrell.
Boston Herald reporter Lindsay Kalter writes that Prof. Ed Boyden is working on a new effort to develop technologies that would allow doctors to explore tumors using virtual reality. Boyden explains that he and his colleagues hope to use virtual reality to explore “what a tumor’s weaknesses are, and what makes it thrive.”
Prof. Bob Weinberg of the Whitehead Institute spoke with Karen Weintraub at WBUR about the best ways to prevent cancer. Reducing obesity and smoking will lead to “decreases in cancer mortality, at least over the next decade or two, that dwarf anything I and my colleagues can produce in terms of new, miraculous cures,” he said.
Prof. Tyler Jacks, director of the Koch Institute, speaks with Meghna Chakrabarti of WBUR’s Radio Boston about cancer research in Boston. Jacks says the large number of researchers in the area “gives us a distinctive advantage,” as it provides researchers the opportunity to interact and collaborate with various institutions.
Boston Globe reporter Priyanka Dayal McCluskey writes that researchers from the Broad Institute and IBM are joining forces to examine why many cancer patients become resistant to drugs. The researchers hope this new effort could “help doctors prescribe more effective combinations of drugs for cancer patients.”
MIT researchers have developed a new technique to stop the spread of cancer cells through the body by delivering microRNAs to the site of the primary tumor, reports Hallie Smith for Boston Magazine. The technique “may correct gene disruptions that put a patient at risk of metastatic cancer,” Smith explains.
Boston Magazine reporter Dana Guth writes that MIT researchers are programming harmless strains of E. coli bacteria to destroy tumor cells. Guth explains that the programmed bacteria could be ingested or injected and “could offer a new way to stave off liver cancer.”
Prof. Susan Lindquist has been named a recipient of the Albany Medical Center Prize in Medicine and Biomedical Research, according to the AP. Lindquist’s research has raised hopes that “treatments could prevent protein ‘misfolding’ that drives degenerative conditions like Alzheimer's, Parkinson's and Lou Gehrig's disease.”